KCM
FURX

Kennedy Capital Management’s FURIEX PHARMACEUTICALS INC COM STK (DE) FURX Stock Holding History

Kennedy Capital Management’s Portfolio FURX Stock Details FURX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-112,256
Closed -$11.9M – 817
2014
Q2 		$11.9M Buy
112,256
+1,335
+1% +$131K 0.22% 149
2014
Q1 		$9.65M Sell
110,921
-3,072
-3% -$237K 0.18% 202
2013
Q4 		$4.79M Buy
113,993
+17,748
+18% +$730K 0.09% 392
2013
Q3 		$4.23M Sell
96,245
-35,034
-27% -$1.45M 0.08% 411
2013
Q2 		$4.47M Buy
+131,279
New +$4.61M 0.09% 382

Kennedy Capital Management's FURX Position: Q3 2014 in Review

Kennedy Capital Management sold out of FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) in Q3 2014, closing a stake of 112,256 shares — an estimated $11.9M sold.

Kennedy Capital Management first reported a position in FURX in Q2 2013 and held it in 5 quarters. The position peaked at $11.9M in Q2 2014. 0 funds tracked by Wall St. Rank hold FURX as of Q3 2014.

  • Kennedy Capital Management reported no remaining FURIEX PHARMACEUTICALS INC COM STK (DE) position as of Q3 2014 after selling out during the quarter.
  • Kennedy Capital Management sold 112,256 FURIEX PHARMACEUTICALS INC COM STK (DE) shares in Q3 2014, an estimated $11.9M.
  • Kennedy Capital Management first reported a position in FURIEX PHARMACEUTICALS INC COM STK (DE) in Q2 2013 and held it in 5 quarters.
  • Kennedy Capital Management's FURIEX PHARMACEUTICALS INC COM STK (DE) position peaked at $11.9M in Q2 2014.
  • 0 funds tracked by Wall St. Rank held FURIEX PHARMACEUTICALS INC COM STK (DE) as of Q3 2014.

Based on Kennedy Capital Management's 13F filing for Q3 2014, filed 14 Nov 2014.